The LaunchPad program is supported through a generous gift from Paul and Diane Manning. Requests for applications for the following LaunchPad translational research programs are open through Thursday, October 29. LaunchPad for Diabetes RFA | Deadline...
UVA Today caught up with Dr. Amy Mathers, associate professor of medicine and pathology, to find answers to a few questions about UVA’s wastewater testing program, which is a joint effort of the University and the UVA Medical Center....
LVG Seed Fund portfolio company Astraea raises more than $7 million....
Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced it has been awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. Th...
An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found. Data from t...
For more than five months now, doctors and researchers at the University of Virginia have been seeking vaccines and effective treatments for COVID-19, investigating the reasons some people are more affected by the disease than others, and treating pa...
The National Science Foundation has awarded the University of Virginia a $1.2 million expansion of an earlier grant to develop a secure, high-performance computing system for research. The new funds are intended to support nationwide adoption of the ...
UVA has selected 14 promising biomedical research projects to receive funding from the Ivy Foundation COVID-19 Translational Research Fund. The projects include development of biosensors, artificial intelligence for testing, vaccine development, nove...
The UVA Licensing & Ventures Group (LVG) is pleased to welcome the newest member of the LVG Seed Fund Investment Committee, Kristin Gunther (Darden ’09). A Principal at Revolution Growth, Kristin brings a wealth of experience in early-stage and s...
Keystone Heart, a medical device innovator driven to redefine the standard of structural heart care, today announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal System....